Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex Vaginal Capsules for Uterine Fibroids
NCT01631903Phase 2Completed
- Sponsor
- Repros Therapeutics Inc.
- Start
- Sep 2012
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of telapristone in Uterine Fibroids (UF), sponsored by Repros Therapeutics Inc.. Started Sep 2012; status: completed.
02
Drugs
telapristone
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT01631903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631903.